TRANSITION AGREEMENTTransition Agreement • February 22nd, 2018 • Dermira, Inc. • Pharmaceutical preparations
This Transition Agreement (this “Agreement”) is made and entered into as of November 6, 2017, by and between Dermira, Inc., a Delaware corporation (“Dermira”), and UCB Pharma S.A., a limited liability corporation incorporated under the laws of Belgium (“UCB”). Terms not otherwise defined herein shall have the respective meanings ascribed to them in the Development Agreement (as defined below).
